300404SZSE

Announcement on the Completion of Repurchase and Cancellation of Certain Restricted Stocks

Boji Pharmaceutical Co., Ltd.··3 pages

✨ AI Summary

The announcement details the completion of the repurchase and cancellation of 230,000 restricted stocks due to unmet performance conditions in the 2023 incentive plan. The total repurchase amount was 1,312,602.21 RMB, affecting four individuals. Following this action, the company's total share capital decreased from 385,975,208 shares to 385,745,208 shares, without changing the actual controller or affecting the company's financial status.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.

Special Reminder:

  1. This repurchase and cancellation involves 230,000 shares of the first category of restricted stocks granted under the 2023 restricted stock incentive plan, which have not yet been released from restrictions, accounting for 0.06% of the total share capital before the repurchase and cancellation.
  2. The number of individuals involved in this repurchase and cancellation is four. The repurchase price for the first grant portion is 5.47 RMB/share plus the interest from bank deposits during the same period, while the repurchase price for the reserved grant portion is 5.46 RMB/share plus the same interest. The total repurchase funds amount to 1,312,602.21 RMB.
  3. The company has completed the repurchase and cancellation procedures for the aforementioned restricted stocks with the Shenzhen branch of China Securities Depository and Clearing Corporation Limited.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.